Hester Biosciences Q3 FY26 Earnings Call Recording

Hester Biosciences makes Q3 FY26 earnings conference call audio recording available on company website following teleconference held on 30 January 2026.

Hester Biosciences Q3FY26 Results Call on Jan 30

Hester Biosciences Limited has scheduled an earnings conference call on January 30, 2026, at 2:00 PM IST to discuss Q3FY26 and nine-month financial results with senior management.

Hester Biosciences Reports Mixed Q2/H1 FY26 Results with 13% Revenue Decline in India Business

Hester Biosciences reported standalone sales of INR 64 crores in Q2 and INR 128 crores in H1 FY26, marking declines of 12% and 13% respectively, with EBITDA and net profit falling 13% and 15% for the half-year period. The company's Poultry Healthcare division showed growth of 18% in Q2 and 10% in H1, while Animal Healthcare declined 50% in Q2 due to delays in government immunization programs, though management expects improved performance in the second half driven by new facility capitalization and H9N2 vaccine commercialization.

Hester Biosciences CFO Divyesh Maru Resigns to Pursue Other Career Interests

Divyesh Maru has resigned from his position as Chief Financial Officer and Key Managerial Personnel at Hester Biosciences Limited, effective from the close of office hours on 13 November 2025. The resignation was submitted to pursue other career interests, with the company acknowledging his contributions during his tenure as CFO.